- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05827640
Expiratory Time Constant in Mechanically Ventilated Patients
Determining Expiratory Time Constant in Mechanically Ventilated Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
Adult patients (n = 30) undergoing elective cardiac surgery with extracorporeal circulation (ECC) were included. Patients were excluded from the study if they had any known lung disease or had previous thoracic surgery. After the surgery, all patients were transferred to the intensive care unit (ICU) and connected to well-established Servo-U (Maquet, Getinge AB, Solna, Sweden) mechanical ventilator. First, the ventilation mode was set to mandatory volume-controlled ventilation (VCV) for 15 minutes. After that, mandatory pressure-controlled ventilation (PCV) for another 15 minutes was commenced. All patients were in supine position, sedated and paralyzed using continuous infusion of propofol and atracurium with no spontaneous breathing efforts. During VCV, an end-inspiratory pause (TPAUSE 10%) has been added to obtain inspiratory plateau pressure (P PLAT) under static conditions. Respiratory variables in VCV for all patients were as follows: PEEP 6 - 9 cmH 2 O depending on the local protocol, protective tidal volume (Vt) of 7 ml/kg/PBW, T PAUSE was set to 10%, I:E ratio of 1:2, rise time 5% and the respiratory rate was 14 breaths/min. After 15 minutes, VCV was changed to PCV with the same ventilator setting with inspiratory pressure set in the way to best match the Vt during the VCV. ARDSNet tables were used to determine PBW for all patients.
A novel device enabling data acquisition (Dr. Wave, Quadrus Medical Technologies, NY, White Plains, USA) has been connected to the Servo-U ventilator after admission to the ICU to record flow, pressure, and volume waveforms. All data in the study were derived from measurements and calculations from this device and included: Peak Inspiratory Pressure (PIP), PPLAT, PEEP, expiratory tidal volume (Vt) respiratory system compliance (C RS ), airway resistance (RTOT) and the peak expiratory flow rate (PEFR).
Based on obtained data of flow, volume and pressure during PCV and VCV, six different methods to determined expiratory time constant were examined
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Košice, Slovakia, 040 01
- East Slovak Institute for Cardiovascular Diseases
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria: cardiac surgery with extracorporeal circulation
-
Exclusion Criteria:
- known pulmonary disease
- previous thoracic surgery
- poor preoperative cardiac status
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Expiratory time constant
Time Frame: 3 months
|
Six different methods to assess expiratory time constants in mechanically ventilated patients
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Validity of expiratory time constant definition
Time Frame: 3 months
|
To prove if three time constant correspond to actual first time constant multiplied by the factor of 3
|
3 months
|
Collaborators and Investigators
Investigators
- Study Director: Dušan Rybár, PhD, East Slovak Institute for Cardiovascular Diseases
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- www.vusch.sk
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on data recording using conventional ventilation strategies (PCV and VCV)
-
Medical University of ViennaAustrian Science Fund (FWF)Active, not recruitingHeart Failure | Artificial Heart Device UserAustria
-
Rennes University HospitalNot yet recruitingHysterectomies for Low- or Intermediate-risk Endometrial CarcinomaFrance
-
NeuroWave Systems Inc.Fraser Health; U.S. Army Medical Research Acquisition ActivityCompletedDepth of Anesthesia (DOA)Canada